IBDEI2VP ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48329,0)
 ;;=20605^^215^2394^2^^^^1
 ;;^UTILITY(U,$J,358.3,48329,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48329,1,2,0)
 ;;=2^Asp/Inj Intermediate Jt w/o US
 ;;^UTILITY(U,$J,358.3,48329,1,3,0)
 ;;=3^20605
 ;;^UTILITY(U,$J,358.3,48330,0)
 ;;=20610^^215^2394^4^^^^1
 ;;^UTILITY(U,$J,358.3,48330,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48330,1,2,0)
 ;;=2^Asp/Inj Major Jt w/o US
 ;;^UTILITY(U,$J,358.3,48330,1,3,0)
 ;;=3^20610
 ;;^UTILITY(U,$J,358.3,48331,0)
 ;;=20550^^215^2394^9^^^^1
 ;;^UTILITY(U,$J,358.3,48331,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48331,1,2,0)
 ;;=2^Inject Tendon/Ligament/Cyst 
 ;;^UTILITY(U,$J,358.3,48331,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,48332,0)
 ;;=J1100^^215^2394^8^^^^1
 ;;^UTILITY(U,$J,358.3,48332,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48332,1,2,0)
 ;;=2^Dexamethasone Sodium Phos 1 mg
 ;;^UTILITY(U,$J,358.3,48332,1,3,0)
 ;;=3^J1100
 ;;^UTILITY(U,$J,358.3,48333,0)
 ;;=J0800^^215^2394^7^^^^1
 ;;^UTILITY(U,$J,358.3,48333,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48333,1,2,0)
 ;;=2^Corticotropin Inj up to 40 units
 ;;^UTILITY(U,$J,358.3,48333,1,3,0)
 ;;=3^J0800
 ;;^UTILITY(U,$J,358.3,48334,0)
 ;;=J1040^^215^2394^10^^^^1
 ;;^UTILITY(U,$J,358.3,48334,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48334,1,2,0)
 ;;=2^Methylprednisolone 80 Mg Inj
 ;;^UTILITY(U,$J,358.3,48334,1,3,0)
 ;;=3^J1040
 ;;^UTILITY(U,$J,358.3,48335,0)
 ;;=20606^^215^2394^1^^^^1
 ;;^UTILITY(U,$J,358.3,48335,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48335,1,2,0)
 ;;=2^Asp/Inj Intermediate Jt w/ US
 ;;^UTILITY(U,$J,358.3,48335,1,3,0)
 ;;=3^20606
 ;;^UTILITY(U,$J,358.3,48336,0)
 ;;=20611^^215^2394^3^^^^1
 ;;^UTILITY(U,$J,358.3,48336,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48336,1,2,0)
 ;;=2^Asp/Inj Major Jt w/ US
 ;;^UTILITY(U,$J,358.3,48336,1,3,0)
 ;;=3^20611
 ;;^UTILITY(U,$J,358.3,48337,0)
 ;;=20604^^215^2394^5^^^^1
 ;;^UTILITY(U,$J,358.3,48337,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48337,1,2,0)
 ;;=2^Asp/Inj Small Jt w/ US
 ;;^UTILITY(U,$J,358.3,48337,1,3,0)
 ;;=3^20604
 ;;^UTILITY(U,$J,358.3,48338,0)
 ;;=97762^^215^2395^1^^^^1
 ;;^UTILITY(U,$J,358.3,48338,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48338,1,2,0)
 ;;=2^C/O for Orthotic/Prosth Use,Est Pt,ea 15min
 ;;^UTILITY(U,$J,358.3,48338,1,3,0)
 ;;=3^97762
 ;;^UTILITY(U,$J,358.3,48339,0)
 ;;=97760^^215^2395^2^^^^1
 ;;^UTILITY(U,$J,358.3,48339,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48339,1,2,0)
 ;;=2^Orthotic Mgmt and Training,ea 15min
 ;;^UTILITY(U,$J,358.3,48339,1,3,0)
 ;;=3^97760
 ;;^UTILITY(U,$J,358.3,48340,0)
 ;;=97761^^215^2395^3^^^^1
 ;;^UTILITY(U,$J,358.3,48340,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48340,1,2,0)
 ;;=2^Prosthetic Training,ea 15min
 ;;^UTILITY(U,$J,358.3,48340,1,3,0)
 ;;=3^97761
 ;;^UTILITY(U,$J,358.3,48341,0)
 ;;=97110^^215^2396^7^^^^1
 ;;^UTILITY(U,$J,358.3,48341,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48341,1,2,0)
 ;;=2^Therapeutic Exercises, Ea 15 Min
 ;;^UTILITY(U,$J,358.3,48341,1,3,0)
 ;;=3^97110
 ;;^UTILITY(U,$J,358.3,48342,0)
 ;;=97750^^215^2396^5^^^^1
 ;;^UTILITY(U,$J,358.3,48342,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48342,1,2,0)
 ;;=2^Physical Perform Test, Ea 15 Min
 ;;^UTILITY(U,$J,358.3,48342,1,3,0)
 ;;=3^97750
 ;;^UTILITY(U,$J,358.3,48343,0)
 ;;=97112^^215^2396^4^^^^1
 ;;^UTILITY(U,$J,358.3,48343,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,48343,1,2,0)
 ;;=2^Neuromuscular Reeduc,  Ea 15 Min
 ;;^UTILITY(U,$J,358.3,48343,1,3,0)
 ;;=3^97112
 ;;^UTILITY(U,$J,358.3,48344,0)
 ;;=97113^^215^2396^1^^^^1
 ;;^UTILITY(U,$J,358.3,48344,1,0)
 ;;=^358.31IA^3^2
